Suppr超能文献

人类胃肠道上皮中的降钙素基因相关肽受体

Calcitonin gene-related peptide receptors in human gastrointestinal epithelia.

作者信息

Cox H M, Tough I R

机构信息

Department of Pharmacology, Royal College of Surgeons of England, London.

出版信息

Br J Pharmacol. 1994 Dec;113(4):1243-8. doi: 10.1111/j.1476-5381.1994.tb17131.x.

Abstract
  1. The secretory responses to calcitonin gene-related peptide (CGRP) receptor agonists have been characterized in two human adenocarcinoma cell lines, namely HCA-7 and Colony-29 (Col-29) epithelia. These cells form polarized epithelial layers when grown on permeable supports and allow changes in electrogenic ion transport in response to agonists to be monitored continuously. 2. alpha-CGRP (rat and human sequences), rat beta-CGRP and human [Tyr0]CGRP applied to the basolateral surface were found to be full agonists, causing prolonged increases in short-circuit current. Concentration-response curves exhibited EC50 values of 0.6-1.5 nM in HCA-7 cells. The same agonists were less effective in Col-29 epithelia, the EC50 values ranging from 1 to 10 nM in these cells. [Cys(ACM)2,7]CGRP was effective in both cell lines and was more potent in HCA-7 cells. 3. CGRP receptors were preferentially located on the basolateral surface in both cell types. Addition of r alpha-CGRP to the apical domain produced significantly smaller secretory responses (8.1% in HCA-7 and 29.2% in Col-29) compared with those produced following basolateral application (100%). 4. In both cell lines r alpha-CGRP-elevated short-circuit current was inhibited by the loop diuretic piretanide (200 microM) and by somatostatin (100 nM). Pretreating epithelia with the cyclo-oxygenase inhibitor, piroxicam (5 microM) had no significant effect upon CGRP responses in either cell line. 5. Rat alpha-CGRP (0.2 nM) responses in HCA-7 epithelia were inhibited by the C-terminal fragment CGRP(8-37) (1 microM). Pretreatment of Col-29 cells with CGRP(8-37) did not, however, alter the size or profile of responses to r alpha-CGRP (1 nM).6. We conclude that high-affinity CGRP receptors exist on the basolateral surface of both cell lines,however they differ in their sensitivity to CGRP(8-37) and agonist orders of potency. Thus different CGRP receptor subtypes appear to predominate in these two epithelial cell types.
摘要
  1. 降钙素基因相关肽(CGRP)受体激动剂对两种人腺癌细胞系(即HCA - 7和Colony - 29(Col - 29)上皮细胞)的分泌反应已得到表征。这些细胞在可渗透支持物上生长时形成极化上皮层,并能持续监测因激动剂引起的电生性离子转运变化。2. 发现应用于基底外侧表面的α - CGRP(大鼠和人序列)、大鼠β - CGRP和人[酪氨酸0]CGRP是完全激动剂,可使短路电流持续增加。在HCA - 7细胞中,浓度 - 反应曲线的EC50值为0.6 - 1.5 nM。相同的激动剂在Col - 29上皮细胞中的效果较差,这些细胞中的EC50值在1至10 nM之间。[半胱氨酸(ACM)2,7]CGRP在两种细胞系中均有效,且在HCA - 7细胞中更有效。3. CGRP受体在两种细胞类型中均优先位于基底外侧表面。与基底外侧应用(100%)相比,向顶端区域添加rα - CGRP产生的分泌反应明显较小(HCA - 7细胞中为8.1%,Col - 29细胞中为29.2%)。4. 在两种细胞系中,rα - CGRP升高的短路电流均被袢利尿剂吡咯他尼(200 microM)和生长抑素(100 nM)抑制。用环氧化酶抑制剂吡罗昔康(5 microM)预处理上皮细胞对两种细胞系中的CGRP反应均无显著影响。5. HCA - 7上皮细胞中大鼠α - CGRP(0.2 nM)的反应被C末端片段CGRP(8 - 37)(1 microM)抑制。然而,用CGRP(8 - 37)预处理Col - 29细胞并未改变对rα - CGRP(1 nM)反应的大小或特征。6. 我们得出结论,两种细胞系的基底外侧表面均存在高亲和力CGRP受体,但它们对CGRP(8 - 37)的敏感性和激动剂效力顺序不同。因此,不同的CGRP受体亚型似乎在这两种上皮细胞类型中占主导地位。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验